Cresco Labs

Cresco Labs Expands Sunnyside in Central Pennsylvania with New Store in Altoona

Retrieved on: 
Thursday, October 5, 2023
Tobacco, Cannabis, Specialty, Food, Beverage, Alternative Medicine, General Health, Pharmaceutical, Health, Retail, Natural Resources, Multimedia, Timeline of cannabis laws in the United States, I-99, Wells & Co, Commonwealth, Caregiver, Cresco Labs, Vail v. Juul Labs, Inc., CL, CSE, FSE, Patient, Drug

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of Sunnyside Altoona in the Commonwealth of Pennsylvania.

Key Points: 
  • Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of Sunnyside Altoona in the Commonwealth of Pennsylvania.
  • View the full release here: https://www.businesswire.com/news/home/20231005449875/en/
    Cresco Labs opened a new Pennsylvania store in Altoona at 534 W Plank Rd.
  • (Photo: Business Wire)
    “We’re excited to expand in central Pennsylvania to meet the strong demand from patients and caregivers for top quality medical marijuana products,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs.
  • Sunnyside Altoona is dedicated to helping qualified patients unlock all the benefits that medical marijuana can provide.

Cresco Labs Expands Florida Brand Portfolio with Launch of FloraCal and Cresco Live Rosin and Flower Products

Retrieved on: 
Thursday, September 21, 2023
Women, Seniors, FDA, Managed Care, Men, Other Retail, General Health, Specialty, Consumer, People with Disabilities, Pharmaceutical, Retail, Cannabis, Hemp, Lifestyle, Alternative Medicine, Other Natural Resources, Health, Vitamins, Supplements, Other Consumer, Natural Resources, CSE, Cresco Labs, Seed, FSE, Multimedia, Patient, Love, CL, NCompass Labs Inc, Library, Arrondissement of Florac, Drug, Hotel

The Company will roll out FloraCal flower, pre-rolls, live rosin concentrates and live rosin chews as well as Cresco flower and pre-rolls at Sunnyside dispensaries starting next week and throughout the fall.

Key Points: 
  • The Company will roll out FloraCal flower, pre-rolls, live rosin concentrates and live rosin chews as well as Cresco flower and pre-rolls at Sunnyside dispensaries starting next week and throughout the fall.
  • View the full release here: https://www.businesswire.com/news/home/20230921915523/en/
    Cresco Labs expanded its brand portfolio in Florida to include a suite of flower and live rosin products from its premium FloraCal and Cresco brands.
  • “A growing number of patients are looking for more premium quality flower options and live rosin products—which is exactly what our FloraCal and Cresco brands offer.
  • Cresco, another decorated cannabis brand, is sold in California, Arizona, Illinois, Michigan, Ohio, Maryland, Pennsylvania, Massachusetts and Florida.

Cresco Labs Opens 33rd Florida Sunnyside in Jacksonville, 70th Store Nationwide

Retrieved on: 
Tuesday, September 12, 2023
Cannabis, Retail, Other Retail, Hemp, Specialty, Natural Resources, CSE, Cresco Labs, Good news, FSE, Multimedia, Patient, Population density, Vail v. Juul Labs, Inc., Château de Florac, CL, Drug, Lorenzo Remedi

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of a second Sunnyside in Jacksonville, Florida.

Key Points: 
  • Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of a second Sunnyside in Jacksonville, Florida.
  • Today’s opening brings Cresco Labs’ store count to 33 dispensaries in Florida and 70 locations nationally.
  • View the full release here: https://www.businesswire.com/news/home/20230912928007/en/
    Cresco Labs opened a new Sunnyside dispensary at 2725 College St. in Jacksonville, Florida.
  • We’re bringing our bestselling branded products to our stores and expanding access to cannabis to more patients—it’s a win-win scenario,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs.

Cresco Labs Launches First-Ever Cannabis Advertisements on Spotify, the World’s Most Popular Audio Streaming Subscription Service

Retrieved on: 
Thursday, September 7, 2023
Entertainment, Cannabis, Tobacco, Specialty, Natural Resources, General Entertainment, Hemp, Celebrity, Retail, Music, Advertising, Communications, Licensing (Entertainment), Cresco, Partnership, CSE, Cresco Labs, FSE, Multimedia, Smart, Corona Labs Inc., CL, Spotify

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it is the first cannabis company to launch cannabis advertisements on Spotify, the world’s most popular audio streaming subscription service with more than 551 million users and 220 million subscribers.

Key Points: 
  • Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it is the first cannabis company to launch cannabis advertisements on Spotify, the world’s most popular audio streaming subscription service with more than 551 million users and 220 million subscribers.
  • View the full release here: https://www.businesswire.com/news/home/20230907185478/en/
    Cresco Labs is the first cannabis company to launch cannabis advertising on Spotify.
  • Pictured is an ad for the company’s national retail brand, Sunnyside.
  • Advertising is supported by a volume-driving paid media campaign that includes programmatic buying, native ads, connectedTV and more.

Cresco Labs Reports Second Quarter 2023 Results

Retrieved on: 
Wednesday, August 16, 2023
Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, Specialty, Cresco, CSE, Cresco Labs, Bank statement, Eastern Time Zone, Tax, FSE, GAAP, Prospectus, Form, Webcast, Depreciation, Growth, Corona Labs Inc., CL, Total, Film industry, Bank, Cryptocurrency, Security (finance), Adjustment

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the second quarter ended June 30, 2023.

Key Points: 
  • Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the second quarter ended June 30, 2023.
  • Second quarter revenue of $198 million, up 2% sequentially, driven by retail growth of 4% and flat wholesale revenue.
  • Second quarter net loss of $43 million, which includes $22 million of impairment charges.
  • On July 30, 2023, Cresco Labs and Columbia Care mutually agreed to terminate the definitive agreement dated March 23, 2022.

Cresco Labs Expands Sunnyside in East Central Florida with New Store in Palm Bay

Retrieved on: 
Monday, August 7, 2023
Cannabis, Retail, Other Retail, Hemp, Specialty, Natural Resources, Cresco Labs, CSE, I-95, Good news, FSE, Multimedia, Patient, CL, Labs, Hospital, Lorenzo Remedi

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No.

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No.
  • 1 producer of branded products, today announced the opening of its 32nd Florida dispensary in Palm Bay.
  • Located at 1260 Malabar Rd., Sunnyside Palm Bay resides along a high-traffic, primary retail corridor directly off the intersection of FL-514 and I-95 (East Florida’s Major North-South Interstate) where people shop, eat and commute daily.
  • (Photo: Business Wire)
    “We continue to expand the Sunnyside brand and increase access to top-quality cannabis products in the most meaningful Florida markets,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs.

SUNNYSIDE ELMWOOD PARK CANNABIS WORKERS JOIN TEAMSTERS LOCAL 777

Retrieved on: 
Wednesday, August 2, 2023
Teamsters Local 1932, Sunnyside, Cresco, Cresco Labs, International Brotherhood of Teamsters, Local, Teamster, Patient, Wellness, Drug

ELMWOOD PARK, Ill., Aug. 2, 2023 /PRNewswire/ -- Wellness Advisors and other cannabis workers at Sunnyside, a subsidiary of Cresco Labs, have voted overwhelmingly to join Teamsters Local 777.

Key Points: 
  • ELMWOOD PARK, Ill., Aug. 2, 2023 /PRNewswire/ -- Wellness Advisors and other cannabis workers at Sunnyside, a subsidiary of Cresco Labs, have voted overwhelmingly to join Teamsters Local 777.
  • "This is the fifth Cresco location to join our union," said Jim Glimco, Local 777 President.
  • "I support the Teamsters because I want to be able to have one job, and not have to work multiple jobs to survive," said Crystal Hernandez, a Wellness Advisor who voted to join Local 777.
  • Founded in 1937, Teamsters Local 777 represents workers in a wide variety of industries throughout the Chicago area.

Cresco Labs to Report Second Quarter 2023 Financial Results on August 16, 2023

Retrieved on: 
Wednesday, August 2, 2023
Cannabis, Natural Resources, Other Retail, Retail, Hemp, Labs, Cresco Labs, CSE, FSE, CL, Drug, Cryptocurrency

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No.

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No.
  • 1 producer of branded products, today announced it will report financial results for the second quarter 2023 on Wednesday, August 16th, 2023 before the market opens.
  • The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Cresco Labs and Columbia Care Mutually Agree to Terminate Merger

Retrieved on: 
Monday, July 31, 2023
Cannabis, Natural Resources, Other Retail, Retail, Hemp, Partnership, Cresco Labs, CSE, Core, FSE, CL, Labs, NEO, Security (finance)

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”) and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”) today announced a mutual agreement, dated July 30, 2023, to amicably terminate the definitive arrangement agreement dated March 23, 2022, as amended on February 27, 2023, pursuant to which Cresco agreed to acquire all of the issued and outstanding shares of Columbia Care (the “Transaction”).

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”) and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”) today announced a mutual agreement, dated July 30, 2023, to amicably terminate the definitive arrangement agreement dated March 23, 2022, as amended on February 27, 2023, pursuant to which Cresco agreed to acquire all of the issued and outstanding shares of Columbia Care (the “Transaction”).
  • “In light of the evolving landscape in the cannabis industry, we believe the decision to terminate the planned transaction is in the long-term interest of Cresco Labs and our shareholders.
  • We want to express our sincere gratitude to Columbia Care for their valuable collaboration and dedication during this transaction,” said Charles Bachtell, CEO and Co-founder of Cresco Labs.
  • We are thankful for the collaboration and partnership with the Cresco team throughout this extensive process,” said Nicholas Vita, CEO and Co-founder of Columbia Care.

Cresco Labs and Khalifa Kush Expand Partnership to Bring Brand’s Premium Products to Massachusetts Cannabis Consumers

Retrieved on: 
Thursday, July 20, 2023
Music, Tobacco, Licensing (Entertainment), Cannabis, Specialty, General Entertainment, Entertainment, Celebrity, Hemp, Natural Resources, Retail, Cresco, Partnership, Cresco Labs, CSE, KK, Genetics, FSE, Multimedia, Sale, CL, Growth, Labs, Drug

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No.

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No.
  • 1 producer of branded products, today announced the expansion of a partnership with Khalifa Kush to exclusively cultivate, manufacture and distribute the cannabis brand’s premium products in Massachusetts.
  • Wiz Khalifa is the multi-platinum-selling, GRAMMY® and Golden Globe® Award-nominated recording artist behind Khalifa Kush.
  • View the full release here: https://www.businesswire.com/news/home/20230720984317/en/
    Through an exclusive partnership between Cresco Labs and the Khalifa Kush brand, flower and pre-rolls from Khalifa Kush will be available for sale starting July 22 at Sunnyside stores throughout Massachusetts.